All modules will now be in held in English and are organised as hybrid events (simultaneous online and, if pandemic circumstances permit, onsite)
Following on from feedback received from our key target audience, the programme leadership have decided to implement the following changes:
- All composite modules of the CAS will be held in English. This makes participation possible for interested persons from all parts of the country as well as from other countries. Depending on the participants and particularly in group work, this can be handled flexibly. In consultation with the supervisors, final written assignments in other languages are also possible.
- All modules of the CAS will be organised as hybrid events, i.e. simultaneous onsite and online events. In practice, this will mean that, if the Covid-19 situation permits, the modules will take place onsite. In addition, online participation is available for all modules.
Please also note that no previous knowledge in sex- and gender-specific medicine is expected in order to attend the CAS.
We are looking forward to exciting discussions, enriched by the different backgrounds and experiences of the participants.
Participate in the information event about the CAS in Sex- and Gender-Specific Medicine via zoom!
Thursday, 7 January 2021, 6:00 – 7:00 pm
Under the title “Men – The Weak Covid Sex”, Swiss Television’s health programme “Puls” focused on Monday 21 September on the sex differences in Covid-19 courses. CAS programme director Catherine Gebhard explains the current theories and presents her research in the section: https://www.srf.ch/play/tv/redirect/detail/d020b6eb-d5ff-4bec-bd1c-cad9be5e2c75
Register today for the first course of the further education program in Sex- and Gender-Specific Medicine, which is unique in Europe: Registration form CAS 2021/22.
It is also possible to register for individual modules only: Registration form module 2021/22.
Cathérine Gebhard, chair of the scientific programme management of the CAS, published a review on the impact of sex and gender on COVID-19 outcomes in Europe. In collaboration with Sabra Klein, Vera Regitz-Zagrosek, Rosemary Morgan, and Hannelore Neuhauser she discusses potential sex-specific mechanisms modulating the course of disease. The article is published in “Biology of Sex Differences”: https://rdcu.be/b4sMZ
Prof. Dr. med. Dr. sc. nat. Cathérine Gebhard, chair of the course directors of the CAS in Sex- and Gender-Specific Medicine, investigates the impact of Sex and Gender on COVID-19 outcomes. The Swiss National Foundation supports the project “Impact of Sex and Gender on COVID-19 outcomes: Role of ACE-2, TMPRSS2, and gender-specific risk factors” (Project), submitted by Gebhard together with Prof. Dr. med. Beatrice Beck Schimmer, one of the initiators of the CAS, CAS-lecturer Prof. Dr. med. Dr. h.c. Vera Regitz and colleagues.
The gender disparities observed in COVID-19 vulnerability clearly emphasize the need to understand the impact of sex and gender on incidence and case fatality of the disease so that treatment in highly vulnerable demographic groups can be timely and tailored to their specific needs. The project will combine clinical data from ongoing cohort studies with retrospective experimental work in mice with. This strategy allows rapid analysis of data and implementation of results. The work will identify both, biological sex- and gender-related predictors of severe variants of COVID-19 and has the potential to contribute to the identification of effective antiviral interventions.
The module “Introduction to Gendermedicine” will take place next year on 10-11 March 2021. Further course dates will be announced continuously.
Given the current situation regarding the new coronavirus we have come to the conclusion that the implementation of the CAS is currently not possible within the desired framework. Since networking and personal exchange of experiences and opinions are an important part of the CAS, we also do not want to conduct the continuing education course online.
Therefore, we have decided to postpone the start of the CAS in Sex- and Gender-Specific Medicine until March 2021. The exact dates of the individual modules will be announced as soon as possible.
Five partially sponsored places are available for the first cohort of the CAS. The program covers 5,000 Swiss francs, and participants must pay the remaining 4,400 Swiss francs. If you are applying for such a place, please explain in your application how you
- want to apply the acquired knowledge in your professional life.
- can act as “ambassador” to increase awareness of gender specific medicine in science and medicine.
If you are interested, please register here.
PhD students receive a 50 percent discount for the entire CAS as well as for the individual modules (please apply under Comments when registering). The costs for PhD students are CHF 4’700 for the whole CAS and CHF 480 for each individual module.